| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 22,173 | 20,659 | 17,860 | 37,566 | | Cost of Revenue | (828) | 6,467 | 6,872 | 12,365 | | | Gross Profit | 23,001 | 14,192 | 10,988 | 25,201 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,236 | 1,143 | 1,136 | 1,573 | | Non Recurring | (221) | 145 | 76 | 272,722 | | Others | 7,533 | 7,494 | 7,562 | 13,703 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,130 | 5,410 | 2,214 | (262,797) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (165) | 135 | 1,152 | 39,136 | | Earnings Before Interest And Taxes | 7,288 | 5,545 | 3,366 | (223,661) | | Interest Expense | 614 | 439 | 633 | 1,360 | | Income Before Tax | 6,674 | 5,106 | 2,733 | (225,021) | | Income Tax Expense |
-
| 28 |
-
| (20) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,674 | 5,078 | 2,733 | (225,001) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,674 | 5,078 | 2,733 | (225,001) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,674 | $5,078 | $2,733 | ($225,001) |
|
0.31% Nasdaq 0.00%
Income Statement
